Evidence map›Paper›PMID 42507247›Full record

ArticleActa neurologica Belgica2026

Late-onset PSP/FTD-like atypical parkinsonism as a novel phenotype of POLG-related disease: a case report.

Gloria Rožmarić, Mario Hero, Eliša Papić, Nadja Grozdanić, Vladimira Vuletić

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Acta neurologica Belgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gloria RožmarićClinic of Neurology, Clinical Hospital Centre Rijeka, Krešimirova 42, Rijeka, 51000, Croatia.
Mario HeroClinic of Neurology, Clinical Hospital Centre Rijeka, Krešimirova 42, Rijeka, 51000, Croatia. mario.hero10@gmail.com.ORCID http://orcid.org/0000-0002-5086-5403
Eliša PapićClinic of Neurology, Clinical Hospital Centre Rijeka, Krešimirova 42, Rijeka, 51000, Croatia.
Nadja GrozdanićClinic of Neurology, Clinical Hospital Centre Rijeka, Krešimirova 42, Rijeka, 51000, Croatia.
Vladimira VuletićClinic of Neurology, Clinical Hospital Centre Rijeka, Krešimirova 42, Rijeka, 51000, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

POLG-related disease is a multisystem mitochondrial disorder that may mimic primary neurodegenerative syndromes. We report a 70-year-old man with progressive cognitive decline, rigid-akinetic parkinsonism, postural instability, vertical supranuclear gaze palsy, and prominent executive and semantic fluency deficits, forming a PSP/FTD-like phenotype. Brain MRI showed frontotemporal-predominant cortical atrophy and a hummingbird sign, while FDG-PET demonstrated frontal and bilateral parietotemporal hypometabolism with preserved occipital metabolism. Alzheimer disease CSF biomarkers were normal and RT-QuIC was negative. Pancytopenia with macrocytosis, liver cirrhosis, and myelodysplastic syndrome indicated multisystem involvement. Genetic testing identified biallelic POLG variants, one pathogenic and one likely pathogenic, confirming POLG-related disease. Levodopa produced partial improvement. This case expands the recognised late-onset POLG spectrum and supports POLG testing in atypical parkinsonism accompanied by cognitive, hepatic, or haematological abnormalities. Early diagnosis may prevent valproate-associated severe hepatotoxicity.

Indexed as

Atypical parkinsonismFrontotemporal dementiaMitochondrial diseasePOLGProgressive supranuclear palsy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.